Search Results 7031-7040 of 18228 for CLL

1. Medical Research & Education - Mayo Clinic News Network

   ROCHESTER, Minn. — Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and increasingly ...

2. A Study to Evaluate Time to First Movement for Fetal Surgery Patients Injected with Intramuscular Anesthesia - Mayo Clinic

   The purpose of this study is to determine the time from intramuscular injection to the time of first fetal movement after a fetal surgery procedure.

3. A Study of the Safety and Effectiveness of Inhaled Mannitol for Adult Patients with Cystic Fibrosis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. COVID-19 - Page 24 of 93 - Mayo Clinic News Network

   Mayo Clinic will begin offering booster vaccines featured image · Mayo Clinic Q&A podcast: FDA panel makes recommendations on COVID-19 booster shots featured.

5. News Releases - 2015 Archives - Page 16 of 16

   Rochester, Minn. (Olmsted County News Release Nov. 9, 2015) – The second Olmsted County Community Health Needs Assessment Survey will be mailed this week ...

6. Lung Cancer Program - Doctors - Mayo Clinic

   Mayo Clinic's Lung Cancer Program practice is one of the most experienced in the United States, with campus in Arizona, Florida and Minnesota.

7. Chondrosarcoma - Doctors and departments - Mayo Clinic

   Learn about this rare type of cancer that primarily affects bone, particularly in the shoulders, hips and pelvis. Treatment usually involves surgery.

8. Central nervous system vascular malformations - Doctors and departments - Mayo Clinic

   Mayo Clinic doctors trained in nervous system conditions (neurologists), nerve surgery (neurosurgeons) and other specialties study central nervous system ...

9. Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305) - Mayo Clinic

   Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide ...

10. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

    This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.